Peptide Therapeutics Market | Forecast up to 2024
This report provides in-depth region wise and country wise analysis of the peptide therapeutics market. Stakeholders of this report include manufacturers of peptide products, raw material suppliers, nutraceutical and cosmeceutical companies, food processing industries and new players planning to enter the market. It further provides qualitative and quantitative analysis of the global peptide therapeutics market. Qualitative analysis comprises market dynamics, trends, product overview, and country-level market information. Quantitative analysis includes major players with their reported revenue, market size, and forecast for the global peptide therapeutics market in major countries globally such as the U.S., Canada, Germany, France, United Kingdom, Switzerland, Spain, Japan, China, Brazil, Mexico, South Africa and Saudi Arabia
Market revenue is provided in terms of US$ Mn from 2014 to 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 for all the segments, considering 2015 as the base year. The executive summary of the report provides a snapshot of the peptide therapeutics with information on leading segments, country wise market information with respect to the market size, growth rate (CAGR %), and growth factors. Moreover, the report also includes pricing analysis for the major peptide drugs worldwide.
The market overview section comprises impact factors such as drivers, restraints, and opportunities for the global peptide therapeutics market. These factors would aid the stakeholders in establishing a strong foothold in the global peptide therapeutics market. Furthermore, the market overview section comprises key industry events, product overview, market attractiveness analysis and emerging trend in the peptide therapeutics market. The market attractiveness analysis provides a graphical view comparing the growth and market dynamics in various segments and country wise to identify the most attractive market.
View Report –
Global Peptide Therapeutics Market: Segmentation
The peptide therapeutics market has been segmented as by application, by route of administration, by type, by technology, by type of molecule, by API peptide type and by geography. Based on application, the market has been segmented into cancer, metabolic, CVD, respiratory, GIT, anti-infective, dermatology, CNS, renal and others. Based on route of administration, the market has been segmented into parenteral, oral and others.
Based on type, the market has been segmented into innovative and generic. Based on technology, the market has been segmented into liquid phase, solid phase and hybrid phase. Based on type of molecules, the market has been segmented into vasopressin, somatostatin, calcitonin, immunopeptide, natriuretic and others. Based on API peptide type, the market has been segmented into in-house and CMO.
Geographically, the peptide therapeutics market has been categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Moreover, analysis for the major countries comprising U.S. Canada, Germany, U.K., France, Italy, Spain, Rest of Europe, Japan, China, India, Rest of APAC, Brazil, Mexico, Rest of LATAM, South Africa, Saudi Arabia, Rest of MEA have also been provided in the report. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the peptide therapeutics market in various regions has been provided in this section. It also includes various ups and downs about particular country or geography that has impacted the overall market globally.
Global Peptide Therapeutics Market: Competitive Analysis
The report provides a detailed outline/blueprint of the peptide therapeutics market globally that will assist new companies in establishing their presence and market players in expanding their market share in the market. It concludes with the company profile section which includes company overview, financial overview, SWOT analysis, product portfolio, business strategies and recent developments for market players. The major players that are profiled in the report include Sanofi, Teva Pharmaceutical Industries Ltd., Novo Nordisk, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Pfizer, Inc. and others.
Request a sample of this report to know what opportunities will emerge in the rapidly evolving Peptide Therapeutics Market during 2016- 2024
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peptide Therapeutics Market | Forecast up to 2024 here
News-ID: 687712 • Views: 471
More Releases from Transparency Market Research - Pharmaceutical
Radiofrequency Ablation Devices Market by Product, Geography and Forecast to 202 …
Transparency Market Research (TMR) has published a new report titled, 'Radiofrequency Ablation Devices for Pain Management Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027'. According to the report, the global radiofrequency ablation devices for pain management market was valued at US$ 543.0 Mn in 2018 and is projected to expand at a CAGR of above 11.0% from 2019 to 2027. Overview Radiofrequency ablation is a minimally invasive surgical
Antithrombin Market Estimated to Flourish by 2025
As per estimates presented in a report by TMR, the demand global antithrombin market will rise at a CAGR of 5.2% for the forecast period of 2017 to 2025. The market for antithrombin is predicted to attract a revenue of US$704.5 mn by the end of 2025 from US$448.2 mn in 2016. The global Antithrombin market is consolidated in nature with a few small-scale vendors that operate in regional markets and
Cancer Vaccines Market - Industrial applications witness fastest growth up to 20 …
Vaccines are medicines that stimulate the immune system of the body to protect against foreign substances. The stimulated immune system destroys foreign bodies and remembers it. Vaccines work on this principle of memorizing foreign particle and prevent infection likely to be caused by this foreign particle when it invades again. Cancer vaccines are medicines categorized as biological response modifiers. These modifiers work by stimulating the immune system to fight against
Bipolar Disorder (BPD) Market - Global Industry Growth and Forecast 2017 - 2025
Bipolar disorder, commonly known as manic depression, is a type of mental illness which is characterized by mood swings. Mood episodes are of two types: manic and depressive episodes. The changes in the mental state bring out sudden high or low moods in a person. An individual suffering from bipolar disorder can be happy, joyful, and energized at a particular moment and can also be sad, hopeless, and sluggish at
More Releases for Based
Increasing demand for biologics for various chronic diseases and rising investment in R&D for the production of biologics is expected to contribute significantly to the growth of plant-based biologics market. According to Biotechnology Innovation Organization (BIO) 2015, over 250 biologic therapies and vaccines have changed the lives of hundreds of millions of patients. Moreover, according to the same source, over 900 biologics are currently (2018) under the stage of development
Hospital-based EMR Market
Electronic medical record (EMR) is a digital version of a paper chart, which contains a patient's medical history. This system is designed to share information with other healthcare providers such as laboratories and specialists. It helps to reduce operational cost such as transcription services and overtime labor expenses. Get Sample PDF of Report@ https://www.alliedmarketresearch.com/request-toc-and-sample/3219 Increase in demand for advanced health monitoring systems drives the growth of the market. In addition, rise in
Plant Based Beverages Market
https://www.qandqmarketresearch.com/reports/7360187/plantbased-beverages-market-87 Plantbased products include plantbased beverages that are further classified into plantbased dairy alternatives, juices, and readytodrink beverages. The plantbased beverages segment is expected to witness a growing CAGR of 6.5% by 2025, owing to the changing eating habits of consumers. Consumers are more conscious about health and wellness than before, and want to consume products that are healthy and natural without compromising on the taste and flavor of the product. Increasing
Plant-based Snacks Market
https://www.qandqmarketresearch.com/reports/7287268/plantbased-snacks-market-24 Plantbased products are those products that are made entirely from plantbased ingredients, and limit or restrict any use of animalbased products. Plantbased products include plantbased snacks, which are further classified into meat alternative snacks, cereal/grainbased snacks, plantbased salted snacks, plantbased snack bars, and fruit and nut snacks. Based on regional segmentation for the plantbased snacks market, North America, Western Europe, and Asia Pacific are estimated to dominate the global plantbased
Account Based Marketing
Today, most of the marketing organizations are moving towards the Account Based Marketing ( ABM ) . The ABM approach has been there for years but the recent technologies available have made this approach scalable and hence more effective and popular. The traditional marketing approach has been around attracting your prospects from a larger pool. The account based marketing is about targeting accounts based on your best business connection. It is
Clinical Nutrition Market 2016: Infant, Milk-based, Soy-based
Latest industry research report on Clinical nutrition products are type of pharmaceutical products, which help to keep patient healthy. They aid to improve metabolic system of the body by providing adequate supplements such as minerals, vitamins and others. Rising instances of chronic and lifestyle diseases and increasing population that receives malnutrition treatment are the major factors responsible for driving the growth of the market. Furthermore, rise in global population, disposable